68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors | MicrobiomeTrials← Back to trialsNCT07639801
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-06Est. Completion: 2026-12-31
Enrollment target: 20 participants Other microbiome trials you might be interested in
Prostate Cancer
The purpose of this study is to evaluate the efficacy, and safety of HRS-5041 tablets combined with antitumor therapy in…
Harbin, ChinaEst. completion Jun 2026
Localised Prostate Cancer
The goal of this randomised clinical trial is to assess whether personalised treatment counselling can improve the decis…
Multiple LocationsEst. completion Nov 2027
Recruiting
Metastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular ImagingTheranostic RadiopharmaceuticalsCancerActive CancerTheranosticRadiopharmaceutical
This is an open-label, first-in-human, exploratory Phase 0 study evaluating the safety and diagnostic imaging performanc…
Perth, AustraliaEst. completion May 30, 2028